Jim Simons Allakos Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Allakos Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 844,233 shares of ALLK stock, worth $253,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

844,233

Previous 725,839 16.31%

Holding current value

$253,269

Previous $471,000 116.77%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.62 - $1.5 $73,404 - $177,591	118,394 Added 16.31%	844,233 $1.02 Million
Q3 2024 Nov 13, 2024	BUY	$0.54 - $0.92 $88,251 - $150,353	163,428 Added 29.06%	725,839 $471,000
Q2 2024 Aug 09, 2024	SELL	$1.0 - $1.45 $293,307 - $425,295	-293,307 Reduced 34.28%	562,411 $562,000
Q1 2024 May 13, 2024	BUY	$1.02 - $3.23 $388,627 - $1.23 Million	381,007 Added 80.26%	855,718 $1.08 Million
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.18 $1.44 Million - $2.66 Million	-835,748 Reduced 63.78%	474,711 $1.3 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $1.23 Million - $3.22 Million	579,548 Added 79.29%	1,310,459 $2.98 Million
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $156,733 - $228,569	43,537 Added 6.33%	730,911 $3.19 Million
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $65,248 - $125,488	15,174 Added 2.26%	687,374 $3.06 Million
Q4 2022 Feb 13, 2023	BUY	$5.66 - $8.42 $204,892 - $304,804	36,200 Added 5.69%	672,200 $5.66 Million
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $173,952 - $352,512	57,600 Added 9.96%	636,000 $3.89 Million
Q2 2022 Aug 12, 2022	BUY	$2.6 - $6.14 $954,200 - $2.25 Million	367,000 Added 173.6%	578,400 $1.81 Million
Q1 2022 May 13, 2022	BUY	$5.08 - $9.81 $1.07 Million - $2.07 Million	211,400 New	211,400 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$76.53 - $110.43 $8.3 Million - $12 Million	-108,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $9.25 Million - $12.4 Million	108,400 New	108,400 $9.25 Million
Q1 2020 May 14, 2020	SELL	$44.49 - $93.39 $498,288 - $1.05 Million	-11,200 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$66.49 - $137.73 $10.1 Million - $20.9 Million	-151,500 Reduced 93.12%	11,200 $1.07 Million
Q3 2019 Nov 13, 2019	BUY	$31.0 - $89.73 $5.04 Million - $14.6 Million	162,700 New	162,700 $12.8 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

68.8M

Call Options Held

20.9K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $25.4M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account